 VANCOUVER and MINNEAPOLIS, MN, Feb. 02, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- Neovasc, Inc. Neovasc or the Company NASDAQ, TSX: NVCN today announced that the German Institute for the Hospital Remuneration SystemInEK has awarded the Neovasc ReducerTM Reducer, a CE-Marked medical device for the treatment of refractory angina, NUB Status 1 designation once again for 2021. 